Antimicrobial resistance trends and lineage distribution among invasive pneumococcal disease isolates pre- and post-pneumococcal conjugate vaccine introduction, South Africa.
Oct 2026· Journal of Infection· Vol 93, pp.
106878
· 0 citations· 50 references
Medicine
TL;DR
PCVs substantially reduced AMR IPD in South Africa, but persistent PCV13 serotypes and expanding resistant non-vaccine-type lineages highlight the potential benefit of higher-valency PCVs, including PCV20.
Abstract
Objectives
Pneumococcal conjugate vaccines (PCV) have reduced antimicrobial-resistant invasive pneumococcal disease (IPD) globally. We evaluated trends in antimicrobial-resistant IPD and pneumococcal lineages before and after PCV13 introduction in South Africa.
Methods
We analysed national, laboratory-based IPD surveillance reported cases (2005-2020) and compared the incidence of resistant-IPD pre- and post-PCV introduction. Antimicrobial susceptibility testing was performed for six antibiotics, and penicillin-multidrug resistance (penicillin-MDR) was defined as penicillin nonsusceptibility plus resistance to ≥2 additional antibiotic classes. Whole-genome sequencing was used to determine serotypes, sequence types, global pneumococcal sequence clusters (GPSC), and antimicrobial resistance (AMR) determinants.
Results
Following PCV introduction, overall IPD and AMR IPD incidence declined substantially. Penicillin-cotrimoxazole nonsusceptible and penicillin-MDR IPD incidence decreased from 5.6 to 0.8 per 100,000 population (percentage decrease -86.5%, confidence intervals [CI] -90.5% to -81.4%) and 5.5 to 0.4 (-93.0%, -95.7% to -89.1%), respectively, in children <5 years, with smaller but significant reductions in the ≥5 years old. Despite these declines, residual PCV13 serotypes, particularly 19A and 19F, continued to contribute notably to penicillin-cotrimoxazole nonsusceptible and penicillin-MDR IPD, respectively, after PCV13 introduction. Non-vaccine serotypes (10A, 15A, 15B/C, 16F, 23B, and 35B) increasingly contributed to resistant IPD in the post-PCV13 era through the expansion of both vaccine-type and non-vaccine-type GPSC lineages.
Conclusion
PCVs substantially reduced AMR IPD in South Africa, but persistent PCV13 serotypes and expanding resistant non-vaccine-type lineages highlight the potential benefit of higher-valency PCVs, including PCV20.
Serotype 3, included in all current conjugate formulations, dominated breakthrough for both vaccines, and in descriptive comparisons limited by small subgroup sizes, neither additional doses nor sequential vaccination was associated with lower vaccine-type proportions.
Shayan Sharifi, S. Pelton, Inci Yildirim et al.· International Journal of Inf...· 0 citations
Invasive pneumococcal disease (IPD) incidence declined sharply during the COVID-19 pandemic and increased again thereafter, coinciding with substantial changes in respiratory virus circulation.
Patricia Brañas, J. C. Sanz Moreno, M. Castaño-Amores et al.· BMC Infectious Diseases· 0 citations
Pneumococcal disease remains a major public health concern in India, with significant prevalence in both children and adults. Pneumococcal conjugate vaccine (PCV) 13 provides high serotype coverage in children and in adults; however, non-vaccine serotypes are emerging. Rising antimicrobial resistance and limited...
S. Taur, M. Keny, N. Kulkarni· BMC Infectious Diseases· 0 citations
Abstract The effectiveness of the 13-valent pneumococcal conjugate vaccine (PCV13) to prevent vaccine-serotype (VT) invasive pneumococcal disease (IPD) in children aged 2–59 months was assessed using data from 4 geographically defined areas in Canada with IPD surveillance, including immunization status. VT IPD cases an...
G. Deceuninck, N. Brousseau, Allison McGeer et al.· Epidemiology and Infection· 0 citations
Streptococcus pneumoniae remains the leading bacterial cause of community-acquired pneumonia (CAP) and a major source of morbidity and mortality in adults. Pneumococcal conjugate vaccines (PCVs) have substantially reduced invasive pneumococcal disease, but serotype replacement has led to shifts in pneumococcal CAP epid...
Samuel Etienne, W. Albrich, M. Pletz et al.· BMC Infectious Diseases· 0 citations
Streptococcus pneumoniae remains a leading cause of invasive disease in children, and nasopharyngeal carriage surveillance is essential for monitoring vaccine-driven changes in serotype distribution. However, carriage data from the Baltic states are scarce. We conducted a cross-sectional study to assess pneumococcal ca...
Hedija Cupeca, I. Zeltiņa, A. Villeruša et al.· PLoS ONE· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.